Abstract:Feline herpesvirus-1 (FHV-1) infection occurs worldwide and is a leading cause of respiratory and ocular diseases in cats. Current vaccines reduce the severity of symptoms but do not prevent infection and, therefore, do not provide defense against an establishment of latency and reactivation. We hypothesize that immunomodulation of FHV-1 is the cause of lack in protection and that deletion of virulence/immune modulatory genes of FHV-1 will enhance safety and immunogenicity. Our objective was to use feline respiratory epithelial cell (FREC) cultures to define in vitro growth characteristics and immunomodulation resulting from infection of FRECs with the virulent FHV-1 strain C27 (WT) and glycoprotein C-deletion (gC-), glycoprotein E-deletion (gE-), serine/threonine protein kinase-deletion (PK-), as well as gE and thymidine kinase-double-deletion (gE-TK-) mutants generated by bacterial artificial chromosome mutagenesis. Differentiated FRECs were mock inoculated or inoculated with WT, gC-, gE-, PK-, or gE-TK- mutants. Virus titration and real-time quantitative PCR assays were performed on samples collected at 1 hpi followed by 24 h intervals between 24 and 96 hpi to determine growth kinetics. Real-time PCR was used to quantitate IFNα, TNFα, IL-1β, IL-10, and TGFβ-specific mRNA levels. Immunoassays were performed to measure the protein levels of subsets of cytokines/chemokines secreted by FRECs. Inoculation of FRECs with gE-TK- resulted in significantly lower end-point titers than inoculation with WT or gE-. Both PK- and gC- inoculated FRECs also produced significantly lower end-point titers at 96 hpi than WT. Overall, intracellular virus titers were higher than those of extracellular virus. PCR results for viral DNA paralleled the virus titration results. Further, in contrast to WT inoculation, an increase in IFNα and IL-10 mRNA expression was not observed following inoculation with gE-TK- and PK-, but inoculation with gE-TK- and PK- did result in increased TGFβ expression in FRECs compared to responses following infection with WT. Moreover, gE-TK- and PK- blocked the inhibition of IL-8 and neutrophil chemoattractant (KC), which was observed following inoculation with WT. In summary, the results obtained in FRECs may be used to predict the safety and immunogenicity characteristics of these mutants in vivo. Our study highlights the value of the FREC system for studying replication kinetics/immune modulation factors of FHV-1 and screening prospective vaccine candidates before their use in experimental cats.

Suppression of Immunodeficiency Virus-Associated Neural Damage by the P75 Neurotrophin Receptor Ligand, LM11A-31, in an in Vitro Feline Model

Feline immunodeficiency virus model to study human immunodeficiency virus/acquired immune deficiency syndrome conditions

Neuronal Apoptosis Is Mediated By Cxcl10 Over-Expression In Simian Human Immunodeficiency Virus-Encephalitis

Choroid Plexus Macrophages Proliferate and Release Toxic Factors in Response to Feline Immunodeficiency Virus

Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats

Early Stages of Feline Immunodeficiency Virus-Infection in Lymph-Nodes and Spleen

Cerebrospinal Fluid is an Efficient Route for Establishing Brain Infection with Feline Immunodeficiency Virus and Transfering Infectious Virus to the Periphery

Compartmentalization and Evolution of Feline Immunodeficiency Virus Between the Central Nervous System and Periphery Following Intracerebroventricular or Systemic Inoculation

Experimental transmission and pathogenesis of immunodeficiency syndrome in cats

Utilizing Feline Lentiviral Infection to Establish a Translational Model for COVID-19 in People with Human Immunodeficiency Virus Infection

Efficient Transduction of Feline Neural Progenitor Cells for Delivery of Glial Cell Line-Derived Neurotrophic Factor Using A Feline Immunodeficiency Virus-Based Lentiviral Construct

Impacts of Antiretroviral Therapy on the Oral Microbiome and Periodontal Health of Feline Immunodeficiency Virus Positive Cats

Feline foamy virus adversely affects feline mesenchymal stem cell culture and expansion: implications for animal model development

Infection with feline immunodeficiency virus alters intestinal epithelial transport and mucosal immune responses to probiotics

Viral replication and innate immunity of feline herpesvirus-1 virulence-associated genes in feline respiratory epithelial cells

Altered cell tropism and cytopathicity of feline immunodeficiency viruses in two different feline CD4-positive, CD8-negative cell lines

Comparison of Antiviral Immune Responses in Healthy Cats Induced by Two Immune Therapeutics

Role of Feline Immunodeficiency Virus in Lymphomagenesis--Going Alone or Colluding?

Reconstitution of Human Immunodeficiency Virus-Induced Neurodegeneration Using Isolated Populations of Human Neurons, Astrocytes, and Microglia and Neuroprotection Mediated by Insulin-Like Growth Factors

Inhibition of Cathepsin B and SAPC Secreted by HIV-Infected Macrophages Reverses Common and Unique Apoptosis Pathways

Improved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134